People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| C2N Diagnostics, LLC | — | Biotechnology | Series B | $35.0M | $49.3M | 2024 |
Dr. Joel Braunstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Joel Braunstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fred Miller | 1 | 2 |
| Dr. Michael Goldblatt | 1 | 1 |
| Micah Onixt | 1 | 1 |
| Dr. David Holtzman | 1 | 1 |
| Dr. Randall Bateman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.